Most Recent
A barrister for the ABC and Fairfax has told the Federal Court that an appeal against the dismissal of their truth defence in the Chau Chak Wing defamation case will have "massive ramifications for mass media".
A group representing patent and trade mark lawyers is seeking to intervene in a high-stakes appeal over computer software patents.
Decorated war hero Ben Roberts-Smith wants to suppress Fairfax's defence in a highly contentious defamation case, saying the media company wanted the "scandalous and vexatious" document public so it could report on it.
Generic drug maker Dr Reddy's Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
The corporate watchdog has won special leave to appeal to the High Court a ruling that found a general store owner in outback South Australia who sold cars by "book up" had not acted unconscionably.
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.
A Copyright Tribunal decision that led to substantially lower sound recording licence fees for Foxtel was "beyond the pale" because it compared fees charged to the cable TV giant with those charged to fitness centres, the Full Federal Court heard Wednesday.
MinterEllison has resolved claims by two directors of failed Solar Shop Australia alleging the law firm, which was retained by the company to advise on a buyback scheme involving $15 million in shares owned by founder Adrian Ferraretto, breached its duty of care.